Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis ...

Our experts agree that there are many simple ways to minimize the chances of breast cancer returning. Adopting a healthy ...

The results of a clinical trial published last month targeted breast cancer "sleeper cells," which are cells that break away ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients.

From blood tests that predict recurrence to smarter, less invasive treatments, 2025 is delivering real hope—especially for ...

A newly developed antibody that restricts the growth of treatment-resistant breast cancers offers new hope for patients. It ...

One participant in the trial, Illeana Casiano-Vazquez, was treated for triple-negative breast cancer, an aggressive cancer ...

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.

Pink Alliance's 22nd annual 'Surviving and Thriving' Luncheon is an event that raises vital funds for local breast cancer ...

Q3 2025 Earnings Call November 6, 2025 8:00 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal Soriot - ...